Inovio Pharmaceuticals INO Cash Flow Statement (2009-2026)

NASDAQ INO
$1.48 +0.02 (+1.72%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Inovio Pharmaceuticals Quarterly Cash Flow Statement

Periods 71 quarters
Latest Sep 2026

Inovio Pharmaceuticals reported cash from operations of -$15.27M and free cash flow of -$15.27M for the quarter ended Sep 2026, up 29.2% year over year. This cash flow statement covers 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-106.95M-79.07M-108.50M-37.78M-54.46M-40.65M-35.53M-33.93M-25.00M-30.47M-32.24M-25.17M-19.38M-19.69M-23.52M-45.50M3.76M-19.68M-6.01M-49.20M
Depreciation and DepletionDep. & Depletion
0.95M0.93M0.94M0.91M0.92M0.71M0.70M0.64M0.57M0.42M0.49M0.42M0.46M0.37M0.36M0.35M0.34M0.32M0.32M0.32M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
0.13M0.13M0.13M0.12M0.12M0.08M0.06M
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.95M0.93M0.94M0.91M0.92M0.71M0.70M0.64M0.57M0.42M0.49M0.42M0.46M0.37M0.36M0.35M0.34M0.32M0.32M0.32M
Share-based CompensationStock Comp.
5.47M7.71M8.34M3.23M3.27M3.81M2.92M2.08M2.27M2.53M1.51M1.24M1.32M1.40M0.83M0.76M0.76M0.70M0.77M0.87M
Deferred Taxes
Gains from Equity InvestmentsGains Equity
0.87M-2.17M4.33M
Gains from Sales and DivestituresGains Divest
-0.43M-0.16M-2.01M-0.33M-0.03M0.05M-0.02M0.04M
Gains from Investment SecuritiesGains Investment
-2.06M-4.84M-4.00M-1.83M2.79M3.22M0.92M-0.22M1.98M-0.69M-0.33M1.33M0.29M0.70M0.78M-0.59M0.01M-2.10M0.09M0.13M
Asset Writedowns and ImpairmentWritedown
0.32M-0.32M2.00M10.51M
Other non-cash itemsOther Non-Cash
1.27M0.23M0.45M-0.40M-0.07M-1.02M-0.55M-1.07M-1.16M-0.71M-2.63M-3.34M1.88M22.52M-20.81M-3.72M-13.87M26.94M
Non-cash ItemsNon-Cash Items
Change in Working Capital
Change in ReceivablesChange Receivables
0.91M-0.54M3.88M-1.29M1.66M-6.70M0.08M-2.97M0.26M0.15M-0.78M0.09M-0.66M0.11M-0.47M0.14M
Change in Account PayablesChange Payables
0.06M0.86M57.23M-30.77M5.28M-40.74M-3.22M-6.69M4.65M-3.16M0.80M-1.98M0.86M-4.16M2.66M-0.35M-4.58M-1.86M2.39M1.72M
Change in Accrued ExpensesChange Accrued Exp.
18.87M-9.00M67.09M-30.77M5.28M-40.74M-3.22M-6.69M4.65M-3.16M0.80M-1.98M0.86M-4.16M2.66M-0.35M-4.58M-1.86M2.39M1.72M
Change in Other Operating AssetsOther Assets Change
-46.56M-7.23M24.16M1.49M-13.83M-39.36M-1.85M1.85M0.26M-1.90M1.83M-0.77M-1.89M-0.18M1.65M-0.77M-1.77M-0.85M1.39M-0.16M
Change in Other Operating LiabilitiesOther Liabilities Change
-4.84M2.20M4.80M-5.01M-3.87M-3.15M-0.09M-1.08M-6.36M0.57M2.48M-1.02M-2.37M-0.20M-0.31M-0.51M-0.35M0.17M-0.48M3.05M
Other Working Capital ChangesOther WC Changes
-0.61M-0.62M-0.65M-0.66M-0.67M-0.69M-0.71M-0.74M0.13M-0.01M-0.45M-0.53M-0.58M-0.59M-0.61M-0.64M-0.65M-0.67M-0.69M-0.72M
Other Operating Activities (as filed)
Cash from OperationsCash from Ops.
-37.89M-61.88M-50.53M-67.47M-36.34M-36.66M-32.31M-29.11M-26.28M-28.76M-28.21M-27.44M-19.66M-26.87M-20.81M-21.57M-19.37M-21.59M-18.05M-15.27M
Investing Activities
Capital ExpendituresCapex
0.64M0.72M0.09M0.17M0.30M0.02M0.04M0.45M0.06M0.03M0.07M0.13M
Sales of Property, Plant and EquipmentPP&E (Sale)
6.07M0.15M0.06M
Change in Property, Plant and EquipmentChange in PP&E
-0.64M-0.72M-0.09M-0.17M5.77M-0.02M0.15M-0.04M-0.45M0.06M-0.06M-0.03M-0.07M-0.13M
Change in IntangiblesChange Intangibless
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
40.49M99.72M39.65M64.17M44.98M80.43M26.31M67.51M29.22M9.75M19.61M24.78M-1.004.95M2.98M-0.99M
Sale and Maturity of InvestmentsInvestments Sold
34.64M123.06M30.07M108.82M99.14M93.66M80.24M62.01M49.02M55.17M30.03M38.86M34.59M0.01M10.26M8.94M0.07M5.61M5.15M3.72M
Other Investing Activities (as filed)Other investing (as filed)
Cash from Investing ActivitiesCash from Investing
-6.49M21.33M-10.30M44.56M54.00M19.00M53.91M-5.49M19.94M45.38M9.97M14.08M34.64M-0.05M5.28M8.87M-0.06M2.64M6.15M3.72M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
16.42M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-16.42M
Short-Term Debt repaymentsST Debt Repayment
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-16.42M
Change in Capital Stock
Common Stock IssuedStock Issued
47.59M29.45M43.26M3.86M6.67M2.92M0.71M1.84M5.23M33.27M-15.48M13.08M1.10M24.92M10.15M1.08M17.21M26.99M
Net Shares Issued and RepurchasedNet Shares Issued
47.59M29.45M43.26M3.86M6.67M2.92M0.71M1.84M5.23M33.27M-15.48M13.08M1.10M24.92M10.15M1.08M17.21M26.99M
Net Equity Issued and RepurchasedNet Equity Issued
47.59M29.45M43.26M3.86M6.67M2.92M0.71M1.84M5.23M33.27M-15.48M13.08M1.10M24.92M0.51M1.08M17.21M26.99M
Other financing activities (as filed)
-3.03M-0.32M-0.05M-0.42M-0.03M-0.01M-0.17M-0.24M-0.01M-0.07M-0.03M0.00M-0.13M-0.06M-811.00
Cash from Financing ActivitiesCash from Financing
47.59M28.42M42.94M3.81M6.67M-0.42M2.88M0.70M1.84M-11.36M33.03M0.66M29.15M1.03M-0.03M24.92M27.13M0.95M17.16M26.99M
Additional items
Exchange Rate EffectFX Effect
-0.01M-0.01M-0.01M-0.02M0.01M0.00M-376.000.00M483.000.03M
Change in Cash
3.20M-12.13M-17.91M-19.11M24.34M-18.09M24.47M-33.91M-4.49M5.29M14.79M-12.70M44.13M-25.90M-15.56M12.22M7.71M-18.00M5.25M15.44M
Ending Cash Balance
71.14M59.01M41.10M21.99M46.33M28.24M52.71M18.80M14.31M19.60M34.39M21.69M65.81M39.92M24.35M36.57M44.27M26.27M31.53M46.96M
Free Cash FlowFCF
-38.53M-61.88M-51.25M-67.55M-36.51M-36.96M-32.34M-29.11M-26.28M-28.80M-28.66M-27.44M-19.66M-26.93M-20.84M-21.64M-19.50M-21.59M-18.05M-15.27M
Net Cash FlowNCF
3.21M-12.13M-17.89M-19.10M24.33M-18.09M24.47M-33.91M-4.49M5.26M14.79M-12.70M44.13M-25.90M-15.56M12.22M7.71M-18.00M5.25M15.44M
Interest Paid
0.53M0.53M0.53M300.000.53M0.53M

Inovio Pharmaceuticals Cash Flow Statement API

Pull Inovio Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY